Trinity Capital Inc. (TRIN)
NASDAQ: TRIN · Real-Time Price · USD
17.09
+0.27 (1.58%)
May 14, 2026, 12:27 PM EDT - Market open

Company Description

Trinity Capital Inc. is a business development company specializing in term loans, equipment financing, and private equity-related investments.

The firm provides tech lending, equipment financing, life sciences, warehouse lending, and sponsor finance sources.

The firm is industry agnostic and invests in growth-stage companies across industries, including aerospace, software, Agricultural Equipment, Alternative Protein, Clean Technology, Energy, Food and Beverage / CPG, Information Technology, Life Sciences, Oil and Gas, Robotics, Semiconductors, Transportation, and consumer and retail.

They provide investors with stable and consistent returns through access to the private credit market.

Trinity Capital Inc. was founded in 2008 and is based in Phoenix, Arizona, with additional offices in Solana Beach, California and San Diego, California.

Trinity Capital Inc.
Trinity Capital logo
CountryUnited States
Founded2007
IPO DateJan 29, 2021
IndustryAsset Management
SectorFinancials
Employees106
CEOKyle Brown

Contact Details

Address:
1N 1st Street, Suite 302
Phoenix, Arizona 85004
United States
Phone480 374 5350
Websitetrinitycapital.com

Stock Details

Ticker SymbolTRIN
ExchangeNASDAQ
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencyUSD
IPO Price$14.00
CIK Code1786108
CUSIP Number896442308
ISIN NumberUS8964423086

Key Executives

NamePosition
Kyle Steven BrownChief Executive Officer, President, Chief Investment Officer and Director
Steven Louis BrownFounder and Executive Chairman
Ryan ThompsonManaging Director of Tech Lending
Philip GagerSenior Managing Director of Tech Lending
Ryan LittleSenior Managing Director of Equipment Financing
Kevin ZeidanManaging Director of Tech Lending
Lindsay Watson P.T.Chief Vibes Officer
Jonathan CheungManaging Director of Credit
Nader MaghsoudniaSenior Managing Director of Portfolio and Credit
Robert C. LakeSenior Managing Director of Life Sciences

Latest SEC Filings

DateTypeTitle
May 12, 2026497ADFiling by certain investment companies of Rule 482 advertising
May 7, 20268-KCurrent Report
May 7, 2026424B2Prospectus
May 6, 202610-QQuarterly Report
May 6, 20268-KCurrent Report
Apr 30, 2026DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) material
Apr 30, 2026DEF 14AOther definitive proxy statements
Apr 10, 20268-KCurrent Report
Feb 25, 202610-KAnnual Report
Feb 25, 20268-KCurrent Report